ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT05365581: enrollment: not set → 398 participants.
Clinical trial NCT05365581: enrollment: not set → 398 participants.
Clinical trial NCT07028853: enrollment: not set → 1000 participants.
Clinical trial NCT03351803 updates: 1. completion date: 2026-05-10 → 2027-05-10 2. primary completion date: 2026-05-10 → 2027-05-10 3. enrollment: not set → 5412 participants
Clinical trial NCT06679140: enrollment: not set → 2330 participants.
Clinical trial NCT06152575: enrollment: not set → 492 participants.
Clinical trial NCT03448042 updates: 1. completion date: 2026-11-30 → 2027-11-30 2. primary completion date: 2026-11-30 → 2027-11-30 3. enrollment: not set → 123 participants
Clinical trial NCT07444320: enrollment: not set → 200 participants.
Clinical trial NCT07221474: enrollment: not set → 180 participants.
Clinical trial NCT05313555 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2025-09-01 → 2022-09-12 3. primary completion date: 2025-09-01 → 2022-09-12 4. enrollment: not set → 23 participants
Clinical trial NCT05419492: enrollment: not set → 47 participants.